Graham Capital Management »

Immunitybio shares owned by Graham Capital Management

Quarter-by-quarter ownership of Immunitybio (IBRX) shares owned by Graham Capital Management from 13F filings

Historical chart of Graham Capital Management investment in Immunitybio

Tip: Access up to 7 years of quarterly data

All positions including Immunitybio held by Graham Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunitybio by Graham Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $83k 42k 1.98

More positions owned by Graham Capital Management

Strategy Cl A New (MSTR)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Applied Digital Corp Note 2.750% 6/0 (Principal)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Fidelity Wise Origin Bitcoin SHS Put Option (FBTC)
Sunrun Note 4.000% 3/0 (Principal)
Purecycle Technologies Note 7.250% 8/1 (Principal)
Rivian Automotive Note 3.625%10/1 (Principal)
Green Plains Note 5.250%11/0 (Principal)
Tilray Brands Note 5.200% 6/1 (Principal)
The Realreal Debt 4.000% 2/1 (Principal)
Groupon Note 4.875% 6/3 (Principal)
Amazon (AMZN)
Calumet Put Option (CLMT)
Eos Energy Enterprises Com Cl A (EOSE)

View all positions for Graham Capital Management

Top funds holding Immunitybio

Vanguard Group
BlackRock
State Street Corporation
Jane Street
Geode Capital Management
Goldman Sachs Group
Susquehanna International
Woodline Partners
AlphaCore Capital
Two Sigma Investments
Charles Schwab Investment Management
Barclays
Tang Capital Management
Northern Trust
Citadel Advisors

View all funds holding Immunitybio